It has been suggested that the circulating lncRNAs H19, HOTAIR, and MALAT1 in bodily fluids, such as plasma, may function as indicators of drug response, risk of tumor metastasis, and recurrence in OC patients after first-line therapy [227]. Here, MALAT1 is linked to neoplasm.